| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/07/2003 | US6503542 Herbal compositions for treating immunological disorders |
| 01/07/2003 | US6503538 Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
| 01/07/2003 | US6503537 Preparation of powder agglomerates |
| 01/07/2003 | US6503534 Pharmaceutical compositions for prolonged peptide release and preparation method |
| 01/07/2003 | US6503532 Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof |
| 01/07/2003 | US6503528 Polymeric compositions and a method of making the same |
| 01/07/2003 | US6503518 Reduced lipid flowable preparations |
| 01/07/2003 | US6503506 Nutrient therapy for immuno-compromised patients |
| 01/07/2003 | US6503505 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 01/07/2003 | US6503482 Non-chlorofluorocarbon aerosol formulations |
| 01/07/2003 | US6503481 Compositions for aerosolization and inhalation |
| 01/07/2003 | US6503411 Stable compositions |
| 01/07/2003 | CA2220923C Process of high purity albumin production |
| 01/07/2003 | CA2214845C Film-forming pharmaceutical composition for transdermic delivery |
| 01/07/2003 | CA2164844C Methods of preparing gas-filled liposomes |
| 01/06/2003 | WO2003004559A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 01/06/2003 | CA2445824A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 01/03/2003 | WO2003000928A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 01/03/2003 | WO2003000922A2 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | WO2003000908A1 A method for introducing a nucleic acid into a eukaryotic cell |
| 01/03/2003 | WO2003000899A1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000778A1 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 01/03/2003 | WO2003000777A2 Multi-arm block copolymers as drug delivery vehicles |
| 01/03/2003 | WO2003000776A1 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/03/2003 | WO2003000771A1 Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same |
| 01/03/2003 | WO2003000739A1 Regioselectively reticulated polysaccharides |
| 01/03/2003 | WO2003000738A2 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 01/03/2003 | WO2003000710A1 Alkyl- and/or alkenyloligoglycoside preparations having reduced magnesium salt concentrations |
| 01/03/2003 | WO2003000647A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents |
| 01/03/2003 | WO2003000485A1 Method and device for producing compression coated tablets |
| 01/03/2003 | WO2003000297A1 Method of promoting nucleic acid transfer |
| 01/03/2003 | WO2003000295A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | WO2003000294A1 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer |
| 01/03/2003 | WO2003000293A1 Pharmaceutical formulation |
| 01/03/2003 | WO2003000292A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 01/03/2003 | WO2003000291A1 Lipid vesicles, process for producing lipid vesicles and method of immobilizing gene on lipid vesicles |
| 01/03/2003 | WO2003000288A1 Methods and compositions for activating endogenous plant pathogen defense pathways |
| 01/03/2003 | WO2003000285A1 Tissue-specific transporter inhibitor |
| 01/03/2003 | WO2003000282A1 Sustained release formulation |
| 01/03/2003 | WO2003000278A1 Ointments |
| 01/03/2003 | WO2003000263A1 Rapid onset formulation |
| 01/03/2003 | WO2003000259A1 Topical application of thiazolyl amides |
| 01/03/2003 | WO2003000243A1 Antimicrobial nanoemulsion compositions and methods |
| 01/03/2003 | WO2003000241A2 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 01/03/2003 | WO2003000240A2 Stable powder inhalation dosage formulation |
| 01/03/2003 | WO2003000239A1 Stable pharmaceutical compositions containing pravastatin |
| 01/03/2003 | WO2003000238A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 01/03/2003 | WO2003000237A2 Biodegradable polymer coompositions |
| 01/03/2003 | WO2003000235A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 01/03/2003 | WO2003000234A1 Porous matrix comprising cross-linked particules |
| 01/03/2003 | WO2003000231A1 Hydration compositions for corneal pre-surgery treatment |
| 01/03/2003 | WO2003000227A2 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | WO2003000226A2 Pharmaceutical compositions containing polymer and drug assemblies |
| 01/03/2003 | WO2003000225A2 Pharmaceutical formulation having a masked taste and method for the production thereof |
| 01/03/2003 | WO2003000224A1 Compositions with controlled release of lactic acid at vaginal level |
| 01/03/2003 | WO2003000202A2 Particles for inhalation having rapid release properties |
| 01/03/2003 | WO2003000201A2 Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications |
| 01/03/2003 | WO2003000193A2 Covalent coupling of botulinum toxin with polyethylene glycol |
| 01/03/2003 | WO2003000191A2 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 01/03/2003 | WO2003000190A2 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 01/03/2003 | WO2003000184A2 Truncated apolipoprotein b-containing lipoprotein particles for delivery of components to tissues or cells |
| 01/03/2003 | WO2003000179A2 Chemically-modified progenipoietin conjugates |
| 01/03/2003 | WO2003000177A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 01/03/2003 | WO2003000175A2 Pediatric formulation of gatifloxacin |
| 01/03/2003 | WO2003000174A2 Compositions and methods for intracellular delivery |
| 01/03/2003 | WO2003000158A1 Pharmaceutical composition |
| 01/03/2003 | WO2003000156A1 Zero-order prolonged release coaxial implants |
| 01/03/2003 | WO2003000113A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2003000075A1 Method for manufacturing of free-flowing powder containing water-dispersible sterols |
| 01/03/2003 | WO2003000068A1 Improved hard sugar coating method |
| 01/03/2003 | WO2003000057A1 Solvent system |
| 01/03/2003 | WO2003000006A2 Stackable low depth tray |
| 01/03/2003 | WO2002087596A3 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 01/03/2003 | WO2002080840A3 Immunity adjuvant containing a complexed metal cation and vaccine containing same |
| 01/03/2003 | WO2002074247A8 Pharmaceutical formulations for sustained release |
| 01/03/2003 | WO2002070594A3 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 01/03/2003 | WO2002066489A3 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 01/03/2003 | WO2002066056A3 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002056915A3 Complex of modafinil and cyclodextrin |
| 01/03/2003 | WO2002049672A3 Conjugates of antibodies and anticancer drugs |
| 01/03/2003 | WO2002045754A3 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 01/03/2003 | WO2002040058A3 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers |
| 01/03/2003 | WO2002036628A3 New multimeric interferon beta polypeptides |
| 01/03/2003 | WO2002034741A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 01/03/2003 | WO2002032375A9 Uses of monoclonal antibody 8h9 |
| 01/03/2003 | WO2002026757A3 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002016429A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002007759A3 Clostridial toxin derivatives and methods for treating pain |
| 01/03/2003 | WO2002000193A3 Multiple stimulus reversible hydrogels |
| 01/03/2003 | WO2001098357A3 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2633595A1 Antibodies against tumor-associated antigenic target (tat) polypeptides |
| 01/03/2003 | CA2489420A1 Oncology drug innovation |
| 01/03/2003 | CA2455288A1 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | CA2452088A1 Compositions and methods for intracellular delivery |
| 01/03/2003 | CA2451974A1 Chimeric immunomodulatory compounds and methods of using the same |